Thomas Karsten Kilvær
Nikita Shvetsov,
Anders Sildnes,
Masoud Tafavvoghi,
Lill-Tove Rasmussen Busund,
Stig Manfred Dalen,
Kajsa Møllersen
et al.:
Fast TILs—A pipeline for efficient TILs estimation in non-small cell lung cancer
Journal of Pathology Informatics 01. abril 2025 DOI
Susanne Ingebrigtsen,
Thomas Karsten Kilvær,
Agnethe Eltoft
:
Adult epilepsy in a North Norwegian County – incidence, prevalence, clinical features, and mortality (2012-2022)
Seizure 2025 DOI
Heidi Holmen,
Are Martin Holm,
Ragnhild Sørum Falk,
Thomas Karsten Kilvær,
Tone Marte Ljoså,
Christopher Ekholdt
et al.:
A Digital Outpatient Service With a Mobile App for Tailored Care and Health Literacy in Adults With Long-Term Health Service Needs: Multicenter Nonrandomized Controlled Trial
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Nikita Shvetsov,
Morten Grønnesby,
Edvard Pedersen,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund,
Ruth Schwienbacher
et al.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021 DOI
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
et al.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
et al.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Human Pathology 2018 DOI
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018 DOI
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
et al.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
et al.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
et al.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Kaja Skjefstad,
Thea Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
et al.:
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
Steroids 2016 DOI
Roy M. Bremnes,
Lill-Tove Busund,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen
et al.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Journal of Thoracic Oncology 2016 DOI
Tom Dønnem,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen,
Sigurd Hald
et al.:
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Annals of Oncology 2016 DOI
Mehrdad Rakaee,
Lill-Tove Busund,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Sigve Andersen
et al.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
et al.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Mehrdad Rakaee,
Samer Al-Saad,
Ramona Johansen Maurseth,
Khalid Al-Shibli
et al.:
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Turid Hellevik,
Samer Al-Saad,
Erna-Elise Paulsen,
Roy M. Bremnes
et al.:
Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers
Sigurd Hald,
Yury Kiselev,
Samer Al-Saad,
Elin Richardsen,
Charles Johannessen,
Marte Eilertsen
et al.:
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
Tom Dønnem,
Sigurd Hald,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Thomas Karsten Kilvær
et al.:
Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
Clinical Cancer Research 2015 DOI
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Ramona Johansen Maurseth,
Samer Al-Saad,
Sigurd Hald
et al.:
CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigurd Hald,
Tom Wilsgaard,
Roy M. Bremnes,
Lill-Tove Busund
et al.:
Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer - A structured review with meta-analysis
Thomas Karsten Kilvær,
Eivind Smeland,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Roy M. Bremnes,
Lill-Tove Busund
et al.:
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Al-Shibli
et al.:
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
Eivind Smeland,
Thomas Karsten Kilvær,
Sveinung Wergeland Sørbye,
Andrey Yurjevich Valkov,
Sigve Andersen,
Roy M. Bremnes
et al.:
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Al-Shibli
et al.:
Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
et al.:
High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
et al.:
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
et al.:
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
et al.:
Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Eivind Smeland,
Roy M. Bremnes,
Lill-Tove Busund
et al.:
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Tom Dønnem,
Eivind Smeland,
Roy M. Bremnes
et al.:
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
International Journal of Oncology 2011 DOI
Anne Bergseng,
Nikita Shvetsov,
Thomas Karsten Kilvær
:
Studie: Slik kan AI revolusjonere lungekreftbehandling
VG : Verdens gang 2025
Heidi Holmen,
Are Martin Holm,
Thomas Karsten Kilvær,
Tone Marte Ljoså,
Lars-Petter Ness Granan,
Christopher Ekholdt
et al.:
Digital Outpatient Services for Adults: Development of an Intervention and Protocol for a Multicenter Non-Randomized Controlled Trial
Heidi Holmen,
Anna Hurrød,
Christopher Ekholdt,
Are Martin Holm,
Thomas Karsten Kilvær,
Lotte Sandberg Larsen
et al.:
Digital outpatient services: development of an intervention and a multicenter controlled trial
2022
Heidi Holmen,
Anna Hurrød,
Christopher Ekholdt,
Are Martin Holm,
Saida Alfrida Martinez Overgaard,
Lotte Sandberg Larsen
et al.:
Digital poliklinikk - utvikling av en intervensjon og en multisenterstudie
2022
Kaja Konstanse Skjefstad,
Thea K.W. Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
et al.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Steroids 2018 DOI
Sigurd Hald,
Yury Kiselev,
Samer Al-Saad,
Elin Helmine Richardsen,
Charles Walquist Johannessen,
Marte Eilertsen
et al.:
Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z
BMC Cancer 2016 DOI
Yury Kiselev,
Andrey Yurjevich Valkov,
Lill-Tove Busund,
Roy M. Bremnes,
Igor Snapkov,
Ingvild Mikkola
et al.:
Transcription factor PAX6 is expressed in human soft tissue sarcomas and confers negative impact on patients' survival
2014
The 50 latest publications is shown on this page. See all publications in Cristin here →